Two-Drug combo takes on painful NF1 tumors in early trial
Disease control
Not yet recruiting
This study tests whether combining two drugs, cabozantinib and selumetinib, can safely shrink plexiform neurofibromas in adults and teens (16+) with neurofibromatosis type 1. About 30 participants will receive the drugs in escalating doses to find the best balance of safety and e…
Phase: PHASE1 • Sponsor: Girish Dhall, MD • Aim: Disease control
Last updated May 12, 2026 13:40 UTC